View in EDS HTML Full Text PDF Full Text

Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma.
Authors: Nobili, Stefania1 (AUTHOR), Napoli, Cristina1 (AUTHOR), Puccini, Benedetta2 (AUTHOR), Landini, Ida1 (AUTHOR), Perrone, Gabriele1 (AUTHOR), Brugia, Marco1 (AUTHOR), Benelli, Gemma2 (AUTHOR), Doria, Morena3 (AUTHOR), Martelli, Maurizio4 (AUTHOR), Finolezzi, Erica4 (AUTHOR), Di Rocco, Alice4 (AUTHOR), Del Fava, Emanuele5 (AUTHOR), Rigacci, Luigi2 (AUTHOR), Di Lollo, Simonetta3 (AUTHOR), Bosi, Alberto2 (AUTHOR), Mini, Enrico1 (AUTHOR) enrico.mini@unifi.it
Source: Leukemia & Lymphoma. Sep2014, Vol. 55 Issue 9, p2071-2078. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.3109/10428194.2013.866665